The Exchange has received the disclosure under Regulation 10(7) in respect of acquisition under Regulation 10(1)(a)(i)of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, ....
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
On 25th November 2025, the promoter family of Indoco Remedies restructured their holdings through an off-market inter-se transfer among immediate relatives, exempt from open offer under Regulation 10(1)(a)(i) of SEBI Takeover Regulations. Kare Family Private Trust (KFPT) and Ms. Aruna Suresh Kare directly acquired 1,30,97,055 equity shares (14.20%) from family members - 3% each from Suresh Govind Kare, Aditi Panandikar and Madhura Kare, and 5.20% from Aruna Kare herself. Additionally, KFPT and Aruna Kare acquired controlling stakes in promoter holding companies SIPL and SHPL, which together hold 37.07% in Indoco, taking combined direct and indirect promoter holding to 51.27%. No consideration was paid as the transfers were executed via Gift Deed and settler contributions to the family trust, purely for succession planning and asset streamlining.
This is a neutral internal family reorganization with no change in overall promoter control, no cash outflow for the company, and no open offer triggered. Shareholders should not expect any impact on stock price or company operations as it is purely a succession-related estate restructuring within the promoter group.